Latest Regulatory Approvals News

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.

Monash University has secured a $799,866 Australian Research Council grant to study brain injury thresholds using HITIQ’s PROTEQT™ instrumented mouthguards, with a $200,000 pre-order confirming commercial momentum.

Sarytogan Graphite Limited has secured a $1.4 million top-up placement from the European Bank for Reconstruction and Development, reinforcing confidence in its graphite project and supporting its feasibility study timeline.

Scout Security has entered a binding agreement to acquire New York-based Roo Inc in a merger of equals, combining their complementary home security technologies and customer bases to create a scalable global security-as-a-service platform.

Orpheus Uranium has executed a Native Title Mining Agreement with the Adnyamathanha Traditional Lands Association, a crucial step toward advancing its Frome and Marree uranium projects in South Australia.

PVW Resources has identified three significant gold-silver drill targets at its Cobb Creek Project in Nevada, setting the stage for a maiden drilling campaign and geophysical surveys in early 2026.

Condor Energy has signed a non-binding MoU with Promigas Perú to jointly explore natural gas supply and distribution opportunities from the Piedra Redonda gas field, aiming to unlock value in northern Peru’s energy market.

Novo Resources reports impressive high-grade gold rock chip assays from its Tibooburra Gold Project, highlighting new targets and advancing exploration with drilling plans underway.

Novo Resources reports standout gold assay results from its Tibooburra Gold Project, revealing new high-grade targets and advancing exploration with drilling plans underway.

Elixir Energy has independently certified an additional 189 BCFe of 2C contingent gas resources in Queensland’s Taroom Trough, lifting its total certified resources to approximately 2.8 TCFe. This milestone underscores the company’s expanding footprint in a key Australian gas basin with promising commercial potential.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

Santana Minerals has been granted a 30-year mining permit for its Bendigo-Ophir Gold Project in Central Otago, surpassing earlier expectations of a 25-year term and providing long-term operational certainty.